Neurocrine Biosciences
NBIX
#1287
Rank
A$22.14 B
Marketcap
$218.75
Share price
0.56%
Change (1 day)
15.82%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): A$0.97 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are A$2.24 Billion. In 2023 the company made an earning of A$0.57 Billion, an increase over its 2022 earnings that were of A$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.97 B68.12%
2023 A$0.57 B62.85%
2022 A$0.35 B73.74%
2021 A$0.20 B-8.82%
2020 A$0.22 B77.78%
2019 A$0.12 B49.83%
2018 A$84.12 M-142.57%
2017 -A$0.2 Billion-14.73%
2016 -A$0.24 Billion53.15%
2015 -A$0.16 Billion46.25%
2014 -A$0.11 Billion29.66%
2013 -A$79.81 Million-3530.8%
2012 A$2.32 M-95.73%
2011 A$54.49 M
2009 -A$76.61 Million-45.38%
2008 -A$0.15 Billion-58.87%
2007 -A$0.35 Billion87.3%
2006 -A$0.19 Billion351.97%
2005 -A$40.28 Million-52.09%
2004 -A$84.07 Million-10.98%
2003 -A$94.44 Million
2001 -A$70.49 Million
1999 -A$31.79 Million108.32%
1998 -A$15.27 Million
1996 A$4.65 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$30.87 M-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.08 B 192.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
-A$51.96 Million-104.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.30 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.56 B 995.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.15 B 957.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$12.06 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$67.09 Million-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA